Healthcare Triangle: receives Nasdaq notice of delisting

What happened

• Healthcare Triangle, Inc. reported that on Oct 1, 2026 it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2), the $1.00 minimum bid price requirement.
• The Staff issued a Staff Delisting Determination notifying the company that its securities are subject to delisting unless the company requests an appeal to a Nasdaq Hearings Panel by Oct 8, 2026; if no appeal is requested, trading would be suspended at the opening of business on Oct 12, 2026 and a Form 25-NSE would be filed with the SEC.

Key details

• Nasdaq Listing Rule 5810(c)(3)(A) normally provides a 180-calendar-day compliance period, but under Nasdaq Listing Rule 5810(c)(3)(A)(iv) the company is not eligible for a compliance period because it effected reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one.
• The company effected a 1-for-249 reverse stock split on Aug 1, 2025 and a 1-for-60 reverse stock split on Feb 10, 2026, resulting in a cumulative reverse split ratio of 1-for-14,940 over the prior two-year period.
• The company intends to timely request a hearing before a Nasdaq Hearings Panel under the Nasdaq Listing Rule 5800 Series; the filing states the hearing request will stay suspension and the Form 25-NSE filing pending the Panel’s decision and any extension period.
• The company intends to present a plan to regain compliance with the bid price rule, which may include effecting a reverse stock split; the filing notes there is no assurance the Panel will grant continued listing or that the company will regain compliance. The company’s common stock will continue to trade under the symbol "HCTI" while the Notice has no immediate effect on listing or trading.

Why it may matter

• Item 3.01 was reported: notice of delisting or failure to satisfy a continued listing rule or standard. This item covers Nasdaq’s determination that the company’s securities are subject to delisting for failure to meet the $1.00 minimum bid price and the company’s stated intent to seek a hearing and present a compliance plan. A filing does not show why the insider traded or why the company acted.